[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

How Personalized Is Multiple Myeloma Treatment and How Is That Changing? Introducing the Individual Risk Model for Myeloma

How Personalized Is Multiple Myeloma Treatment and How Is That Changing? Introducing the Individual Risk Model for Myeloma image

How Personalized Is Multiple Myeloma Treatment and How Is That Changing? Introducing the Individual Risk Model for Myeloma

Webinar
event Oct 09, 2024 / 10:30AM - 11:30AM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

As new targets and therapies are being discovered, the landscape of Multiple Myeloma treatment options is quickly evolving. How personalized are current treatment options, and how is that changing? Dr. Benjamin Diamond will join us to answer that question and give us an overview of IRMMa (Individual Risk Model for Myeloma) and it's implications for the future.

Event Highlights

Precision Medicine in Multiple Myeloma

expand_more

Challenges in Treating High-Risk and Relapsed Multiple Myeloma

expand_more

Toxicity and Precision in Immunotherapy

expand_more

The Role of Genomics in Treatment and Personalization

expand_more

Questions & Answers

expand_more

Schedule & Agenda

The panelist Cynthia Cahoon, RN
10:30 AM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Dr. Benjamin Diamond

The panelist Benjamin Diamond, MD
10:35 AM
Presentation
Benjamin Diamond, MD

Dr. Diamond talks about the landscape of Multiple Myeloma treatment

Event panelist Audience
11:05 AM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon, RN
Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Benjamin Diamond, MD
Benjamin Diamond, MD

Dr. Diamond is a hematologist/oncologist who specializes in the treatment of plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma. He completed fellowship at Memorial Sloan Kettering Cancer Center, spending a year as chief fellow, and is now an Assistant Professor at Sylvester Comprehensive Cancer Center is a member of the Myeloma Genomics Laboratory participating in translational research. His research interests include utilization of minimal residual disease (MRD)-guided approaches to clinical decision-making, maintenance therapy, and the genomics of multiple myeloma and secondary malignancies that occur in patients treated for multiple myeloma.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Disease Progression and Relapsed/Refractory group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.